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Abstract
The patient was a 91-year-old man with change in nipple appearance, itching and redness, and a palpable breast
mass. At presentation, mammary Paget’s disease (PD) was clinically suspected. Skin biopsy was performed and showed
epidermis invaded by Paget cells, characterized by hyperchromatic nuclei and abundant pale-staining cytoplasm.
Computed tomography and mammary ultrasonography confirmed the absence of an underlying invasive carcinoma,
and the patient underwent right mastectomy and sentinel lymph node biopsy (SLNB). Both sentinel lymph nodes were
found to be negative perioperatively, and further axillary dissection was not performed. Pathological results revealed no
malignancy under the nipple, yet the Paget cells were more widely spread than expected. The patient was followed up
without the need of postoperative chemotherapy. Male mammary PD is an extremely rare breast cancer, and there is
no standard preoperative assessment or operative procedure. Mammography is many times unable to detect possible
underlying breast carcinoma in female patients with mammary PD, and previous studies have reported that the
detection rate was less than 50 %. However, some researchers reported that magnetic resonance imaging (MRI) might
be more detectable to confirm the extent of the cancer. The extent of the skin change around the nipple is often
different from the actual perimeter of Paget cells. In extra-mammary PD, mapping biopsy is known to be useful to
determine areas free of cancer. The benefits of SLNB have also been demonstrated for the management of less
invasive breast cancers, and previous reports have shown that the use of SLNB is reasonable for treatment of
mammary PD without underlying invasive cancer. MRI, mapping biopsy, and SLNB are all less invasive procedures
and thus may be suitable for treatment of male mammary PD.
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Background
Mammary Paget’s disease (PD) is rare and comprises
about 1 % of all breast cancers. Male breast cancer is
also uncommon, representing approximately 1.0 % of all
breast malignancies. Thus, male mammary PD of the
breast is an extremely rare occurrence [1, 2]. Between
1980 and 2015, eight case reports were identified from
the MEDLINE by keywords, “mammary Paget disease,
man” (Table 1). Most patients with mammary PD
initially note the presence of redness, erosion, or prur-
itus of the nipple and are diagnosed by skin biopsy or
nipple discharge cytology, which is characterized by
malignant glandular cells with clear cytoplasm and
eccentric, hyperchromatic nuclei within the epidermis.
PD of the breast is accompanied by invasive or noninva-
sive underlying carcinomas in 84~94 % of the cases [3–5],
and the prognosis of mammary PD is correlated with the
stage of the underlying carcinoma. From the preoperative
assessment of the extent of the spread of the tumor,
surgeons decide the operative management of the mam-
mary PD, mastectomy with or without an axial lymph
node dissection. This report presents a preoperative and
surgical strategy for male mammary PD.
Case presentation
The patient was a 91-year-old man with no family history
of testicle, breast, and ovarian disease, who noted itchiness
and redness around his right nipple with a palpable mass
underneath (Fig. 1). Physical examination revealed a 1.0-cm
movable mass underneath the nipple with no axial
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lymphadenopathy. The full-thickness skin biopsy identified
Paget cells in the epidermis, and immunohistochemistry
showed these cells were stained strongly for cytokeratin 7,
cytokeratin 20, and with alcian blue and was negative for
gross cystic disease fluid protein 15; these results were
consistent with PD. The evaluation of the overexpression
of human EGFR-related 2 protein showed weakly positive
cells (score2: equivocal). The mass under his nipple was
diagnosed as gynecomastia by mammary ultrasonography
(Fig. 2). Blood examination showed normal tumor
markers (squamous cell carcinoma, 1.1 ng/dl, carcinoem-
bryonic antigen, 5.2 ng/dl, carbohydrate antigen 15–3,
9.6 ng/dl) and normal liver function. Computed tomog-
raphy confirmed absence of an invasive tumor and distant
metastases. The patient underwent right total mastectomy
and right sentinel lymph node biopsy. Two sentinel lymph
nodes were removed, and due to no metastases in the
axilla, axillary lymph node dissection was not performed.
No underlying carcinoma was found in the resected speci-
men, and Paget cells were found to be spread more exten-
sively to the skin than expected (Fig 3), although the
resected margin was negative (Fig. 4). Due to the patient’s
age and no invasive nest other than Paget infiltration to
the skin, the patient was followed up without the need of
postoperative adjuvant therapy.
Conclusions
Between 1980 and 2015, eight case reports were identi-
fied from the MEDLINE (Table 1). The age of patients
Table 1 Mammary Paget’s disease of the man in the literature
Patient no. Author Age Symptoms Palpable mass Treatment Axillary metastasis Follow-up
1 Lancer HA [9] 81 Irritation,
redness
− Mastectomy − Disease free 5
months




+ Disease free 8
years
3 O’Sullivan ST [1] 72 Erythema,
eczema
+ Simple mastectomy N/A alive 9 months




+ Disease free 5
months
5 Nakamura S [8] 83 Bloody discharge,
pigmented
− Simple mastectomy N/A Disease free 9
months
6 Bernardi M [19] 52 Discolored,
pruritus
− Failed to return
for follow-up
N/A N/A
7 Ucar AE [10] 74 Bilateral excoriation rt + lt − Mastectomy adjuvant
chemo-radiotherapy
− N/A
8 Harroudi T [2] 61 Pruritus, erythema + Mastectomy adjuvant
chemo-radiotherapy
− Disease free 2
years
9 Current case 91 Itching, redness − Mastectomy SLNB − Disease free 1
years
Fig. 1 Right breast at initial presentation. Erosion and redness of
the nipple were noted, and lateral accretion of Paget’s disease was
suspected. A 1.0-cm movable lump was identified in the breast
Fig. 2 Mammary ultrasonography. A poorly marginated and low
echoic area was detected under the nipple. The palpable mass was
diagnosed as gynecomastia
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varies from 52 to 91 years. Almost all patients presented
to the outpatient department with a chief complaint of
skin changes around the nipple. Some also noticed the
nipple bloody discharge, and only one did an underlying
palpable mass as a primary symptom [6–8]. In physical
examinations, none of them had axillary lymphadenop-
athy, but at least two patients had axillary metastases in
the resected specimen [6, 7]. The rate of patients with-
out underlying carcinomas may be higher than females.
However, much a short follow-up period, none of the
patients have died of the recurrence of the mammary
PD. Because survival depends on the stage of the under-
lying carcinoma, the low rate of the underlying tumor
seems to result in good prognosis [2, 6, 9, 10]. The ef-
fectiveness of axillary lymph nodes dissection, irradi-
ation, or adjuvant chemotherapy for male mammary PD
is still uncertain, but as with female mammary PD, these
options should be considered on the basis of the stage of
cancer progression.
In clinically suspected cases of mammary PD, full-
thickness skin biopsy is used to pathologically obtain a
diagnosis as mammary PD, and mammography and
mammary ultrasonography are used to identify the pres-
ence of an underlying carcinoma. Female mammary PD
patients (84~94 %) had an underlying invasive or nonin-
vasive carcinoma [3–5]. However, mammography is able
to detect only 47~59 % of the underlying neoplasms
confirmed by histology [3, 11, 12]; one-third of PD pa-
tients had an invasive cancer without a palpable mass or
mammographic finding [5]. On the other hand, magnetic
resonance imaging (MRI) is able to reveal the presence
of 78~98 % of underlying cancers, and Amano et al. has
suggested that MRI is very useful to assess the extent of
these cancers accurately [3, 13].
Some investigators have reported that local recurrence
is possible in patients with PD. One possible cause of
recurrence may be insufficient preoperative evaluation
of the lateral and vertical extent of the disease. In the
present case, the extent of malignancy in the resected
specimen was inconsistent with the gross changes of
skin condition. Intraoperative consultation may be help-
ful for confirmation of the negative resection stump. For
example, in patients with extra-mammary PD, mapping
biopsy is often used preoperatively to evaluate dermal
infiltration, and a 1-cm margin resection is acceptable
[14–16].
Sentinel lymph node biopsy (SLNB) has been used as
a standard option in clinically node-negative mammary
cancer although the effectiveness of the use of SLNB for
treatment of mammary PD has not been established.
Laronga et al. published a database review comparing 36
patients with mammary PD who underwent SLNB and
18 patients who did not undergo SLN; 7 patients had
sentinel lymph node metastases, all of which were asso-
ciated with an underlying carcinoma. However, overall
and disease-free survival did not differ significantly
between the groups [17]. Two other reports have shown
that not only patients with underlying invasive carcin-
oma had sentinel lymph node metastases but also
patients without clinical evidence of an underlying car-
cinoma [18]. Therefore, because the reduced invasive-
ness of SLNB, this procedure was worth considering in
the present case regardless of findings suggestive of an
underlying carcinoma.
Although almost all the studies above have been
with female mammary PD patients, given the reduced
invasiveness of MRI, mapping biopsy, and SLNB, we
suggest the use of these procedures for male patients
with mammary PD to accurately assess the extent of
the tumor.
Fig. 3 Histopathological findings of the resected specimen
(Hematoxylin-eosin stain, ×100). Paget’s cells, which were
characterized by clear cytoplasm and hyperchromatic nuclei, were
detected within the epidermis. Deep infiltration was not observed
Fig. 4 Excised specimen from the mastectomy. A histopathological
cancer map of the mastectomy specimen with the bold pink lines
showing the detected malignant area. This area was not consistent
with the preoperative assessment. Negative margins were confirmed
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Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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